Breaking News, Financial News

Financial Report: AMRI

Unaudited revenues up 44% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 4Q Revenues: $67.2 million (+44%) 4Q Earnings: $1.9 million (loss of $24.4 million in 4Q11) FY Revenues: $226.7 million (+9%) FY Loss: $3.8 million (loss of $32.3 million FY11) Comments: Contract revenue in the quarter was $59.1 million, up 50%. Development/Small Scale Manufacturing revenue was $10.4 million, up 41%. Large Scale Manufacturing revenue was $38.1 million, up 69%. Discovery Services revenue was $10.6 million, up 12%. Royalty revenue in the quarter was $8.1 million, up 13%....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters